. In 1980, the American Psychiatric Association (APA) first included the condition -known then as ' transsexualism/gender identity disorder'-in the Diagnostic and Statistical Manual (DSM) 5 , acknowledging the possibility that it could exist in children or adolescents. The inclusion of gender variance in a psychiatric manual was seen by many to pathologize nonconforming gender identity and expression, and to reinforce gender stereotypes. However, substantial changes have been made to the diagnostic criteria over the subsequent 30 years in an attempt to better define the condition and to find a balance between the competing issues of stigma and access to care [6] [7] [8] [9] . In 2013, APA renamed the condition 'gender dysphoria' in order to better characterize gender-related discomfort 8 . The core feature of gender dysphoria is a marked incongruence between one's experienced and/or expressed gender and assigned gender (usually assigned at birth, and referred to as natal gender), of at least 6 months' duration. However, according to DSM-5, different diagnostic criteria apply to adults and adolescents on one hand, and children on the other 8 . Whereas only two gender-variant behavioural manifestations are required to diagnose gender dysphoria in adults and adolescents, six criteria are required to reach the diagnosis in children, one of which must be the clinical 1 evidence of the child's strong desire to be of the nonnatal gender or insistence of being the non-natal gender 8 . Furthermore, clinically significant psychosocial distress or impairment is needed in order to diagnose gender dysphoria, regardless of the age of the individual 8 .
Development of gender identity.
Gender identity serves as a social identity at an individual as well as a collective level. Its development begins at an early stage of human life; research has shown that around the age of 3 years, children show a basic sense of self as male or female 10 , owing to their inner experi ence of belonging to one gender 11, 12 . Furthermore, at 6-7 years of age a child realizes that one's gender is likely to remain constant [13] [14] [15] . Some research suggests that a developmental lag exists in gender constancy acquisition in children with gendervariant behaviour 16 . Achieving gender constancy represents a cognitive-developmental milestone in gender identity development [17] [18] [19] and is due to the understanding that being male or female is a biological characteristic that cannot be changed by altering superficial attributes, such as hairstyle or clothing 11 . The ability to classify oneself and others as male or female also has strong affective components 20 . Epidemiological studies on the incidence and prevalence of gender-variant behaviour and gender dys phoria are usually based on patients presenting at gender identity clinics, and efforts to achieve realistic estimates are fraught with difficulties [21] [22] [23] [24] . The incidence of gender dysphoria is regarded as remaining constant, whereas the prevalence of the condition has shown great variation between the first and the most recent studies, diverging among countries and even between different epochs within the same country. Prevalence estimates are strongly affected by recruitment strategies, diagnostic criteria, treatment availability, and eligibility 23, 24 .
A 2015 meta-analysis of 21 studies concluded that the prevalence of gender dysphoria is 1 in 14,705 in adult males and 1 in 38,461 in adult females 25 . Moreover, an interesting study has indicated that the numbers of referrals to specialized clinics for gender dysphoria have increased between 2006 and 2013 together with a corresponding shift in the sex ratio, from one favouring natal males to one favouring natal females 26 . Although gender-variant behaviour has been shown to be frequent in children, ranging from 2-23% for natal males and 4-39% for natal females 27, 28 , numbers are definitely smaller when considering gender-variant adolescents reporting discontent with their assigned gender and/or seeking hormone treatment or some form of surgery (0.6% of the natal males and 0.2% of the natal females) 29 . These findings seem to suggest that there is not a direct relationship between the experience of gender-variant behaviour, the dislike of one's natal sex characteristics, and the desire to undergo sex reassignment procedures, providing support for a dimensional approach to gender dysphoria 29 . In contrast to studies of gender-variant behaviour, studies attempting to investigate the prevalence of gender dysphoria according to the DSM-5 diagnostic criteria 8 report even lower rates in adults, ranging from 0.005-0.014% for natal males and 0.002-0.003% for natal females 8 . Very little is known about the trajectory of the condition in gender-variant children who meet the criteria for a gender dysphoria diagnosis as an adult. The percentage of children initially diagnosed with gender dysphoria who display persistence of the condition ranges from 12-27% [30] [31] [32] , indicating that the majority of children meeting gender dysphoria criteria do not have persistence of the condition by the time they have entered puberty. This finding could be partially explained by the internalized social pressure to conform 33 , although this hypothesis is still untested 34 . However, the possibility of an original misdiagnosis (false positive) should also be considered 33, 34 . Regardless of these limitations, it is thought that an increased number and intensity of gender-variant phenomena in childhood, gender dysphoria persistence in adolescence, and cognitive dimensions of gender identity nonconformity (rather than emotional dimensions) could predict an increased likelihood of gender dysphoria persistence into adulthood [35] [36] [37] . Clinical evidence in children. Gender variance is conceptualized as a spectrum of gender-identity-related phenomena rather than a homogeneous phenomenon 24 . In an attempt to define possible gender-dysphoriarelated characteristics and predictors of outcome, two subtypes of gender dysphoria have been suggested, an early-onset (prepubertal) group and a late-onset (peripubertal or postpubertal) group 8 . Some researchers and clinicians have suggested that early-onset genderdysphoric individuals might present with more constant forms of gender dysphoria or gender variance from childhood onwards than the late-onset group and identify with homosexual sexual orientation more frequently, and could benefit from early medical intervention 24, 38 . Children in the early-onset group can experi ence substantial distress at the physical changes of puberty and gender dysphoria can even become more intense at this time 24 . Instead, late-onset gender dysphoric individuals could present with a more fluctuating gender-variant behaviour, not necessarily needing gender reassignment 24 .
Key points
• Puberty suppression using gonadotropin-releasing hormone analogues is prescribed to relieve the distress associated with pubertal development in adolescents with gender dysphoria, in order to provide time for further exploration • Treating prepubertal individuals with gender dysphoria is particularly controversial owing to their unstable pattern of gender variance compared with gender-dysphoric adolescents and adults • The absence of robust data in support of or against the use of puberty suppression in childhood-onset gender dysphoria has led to inconsistencies between health-care pathways across different centres • The paucity of evidence of the effect of puberty suppression on health-related outcome measures calls for studies that might help to advance the evidence-based debate on risks and benefits • Despite a limited number of studies, the existing literature supports puberty suppression as an early, sufficiently safe, and preventive treatment for gender dysphoria in childhood and adolescence
Regardless of the course of the condition, it is not possible to safely differentiate between children who will show persistence of gender-variant behaviour in adulthood from those who will instead show desistence and conform to their natal gender 39 . The optimal approach to treating prepubertal children with gender dysphoria is, therefore, still a matter of contention and is more controversial than treating the condition in adolescents and adults, who are more likely to express a stable pattern of gender variance 39 . Furthermore, research into treatment outcomes in children with gender dys phoria is still at an early stage, with only a few studies that have investigated the effect of puberty suppression on psycho social functioning and mental wellbeing [40] [41] [42] . To date, only one long-term follow-up study has indicated that a treatment protocol including puberty suppression leads to a psychosocial functioning in late adolescence that is comparable to non-gender-dysphoric peers 41 . Moreover, randomized controlled trials to study treatment outcomes in children with gender dysphoria are still needed 43 . According to the WPATH Standards of Care, adolescents should be considered eligible for puberty suppression based on five criteria: evidence of gender dysphoria from early childhood onwards, an increase in the intensity of gender dysphoria after the first pubertal changes, no signs of psychiatric comorbid ity, provision of adequate psychological and social support during the treatment, and demonstration of knowledge and understanding of the effects of puberty suppression by the patient 3 .
Approaches to treatment in childhood. The report from the APA Task Force on treatment of gender dysphoria 39 has highlighted the challenging issue of capacity in children when considering treatment options; from a developmental point of view, children are regarded as not having the ability to make decisions and they lack the legal ability to provide informed consent. Treatment for gender dysphoria -especially puberty suppressionis particularly controversial and no agreement has been reached among clinicians and researchers on a specific care pathway for gender dysphoria in childhood. As a consequence, treatment options need to be discussed in a wider context, in which caregivers have the responsibility of making treatment decisions on the patient's behalf, with potentially lifelong consequences.
Experts and health-care providers agree that psychotherapy represents a fundamental part of treatment for gender dysphoria in childhood, in order to promote the individual's self-confidence and wellbeing. One study has indicated that psychological support after diagnosis has an effect on its own in improving the psychosocial functioning of gender-dysphoric adolescents 40 . However, clinicians disagree on what they consider the main goal of offering psychological support to young people with gender dysphoria. Three different approaches can be identified, which use divergent clinical paradigms to address the issue of gender dysphoria in children. The first approach relies on the concept that minimization of gender-variant behaviour in children should be actively promoted in order to reduce the likelihood of gender dysphoria persistence in adulthood 43 . Personal, philosophical, or ethical considerations regarding the inappropriateness of allowing gender-variant behaviour in children, as well as practical issues, such as the high cost of gonadotrophin-releasing-hormone antagonists (GnRHa) for puberty suppression and other sexual reassignment procedures, lead some clinicians to consider persistence of gender dysphoria into adulthood undesirable [43] [44] [45] . Some clinicians criticize the medical treatment of young individuals with gender dysphoria, stating that a diagnosis of gender dysphoria cannot be made in preadolescents, as their gender identity is still fluctuating and developing 33, 34 . Other professionals fear that puberty suppression could crystallize gender dysphoria, inhibiting the development of a gender identity correspondent to the natal sex 46 . Most importantly, this approach is based on the evidence is that only a minority of those with untreated childhood gender dysphoria will identify as transsexual or transgender in adulthood, while the majority will become comfortable with their natal gender over time 33, 34, 44 . Furthermore, concerns have been raised regarding the risks of puberty suppression -including effects on brain development and other physical issues, such as bone density alteration -which are still not fully understood 39, 47 . To date, only one study has assessed the effect of GnRHa on cognition in gender dysphoria, reporting no evidence for a deleterious effect of puberty suppression on brain activity and related executive functioning 48 . Also, bone mineral density has been recently studied for the first time in a cohort of gender-dysphoric individuals receiving puberty Box 1 | Tanner stages Pubic hair (both male and female) Tanner 1: no pubic hair at all (typically age 10 years and under) Tanner 2: small amount of long, downy hair with slight pigmentation at the base of the penis and scrotum (males) or on the labia majora (females) (age 10-11 years) Tanner 3: hair becomes more coarse and curly, and begins to extend laterally (age 12-14 years) Tanner 4: adult-like hair quality, extending across pubis but sparing medial thighs (age 13-15 years) Tanner 5: hair extends to medial surface of the thighs (age 16+ years) Genitals (male) Tanner 1: prepubertal (testicular volume less than 1.5 ml; small penis of ≤3 cm) Tanner 2: testicular volume 1.6-6 ml; skin on scrotum thins, reddens and enlarges; penis length unchanged Tanner 3: testicular volume between 6-12 ml; scrotum enlarges further; penis begins to lengthen to about 6 cm Tanner 4: testicular volume between 12-20 ml; scrotum enlarges further and darkens; penis increases in length to 10 cm Tanner 5: testicular volume >20 ml; adult scrotum and penis of 15 cm in length Breasts (female) Tanner 1: no glandular tissue; areola follows the skin contours of the chest (prepubertal) Tanner 2: breast bud forms with small area of surrounding glandular tissue; areola begins to widen Tanner 3: breast begins to become more elevated and extends beyond the borders of the areola, which continues to widen but remains in contour with surrounding breast Tanner 4: increased breast size and elevation; areola and papilla form a secondary mound projecting from the contour of the surrounding breast Tanner 5: breast reaches final adult size; areola returns to contour of the surrounding breast, with a projecting central papilla A second approach considers it crucial not to interfere with the child's development. Compared with the first approach, this ethos does not consider a therapeutic target to lessen gender-variant behaviour and instead promotes neutrality with respect to the patients' gender identity outcome. Like the first approach, the basis of this strategy is the absence of clear-cut predictors of gender dysphoria persistence in adulthood and the evidence that a substantial percentage of gender-variant behaviour in childhood will not culminate in adult gender dys phoria 30, 44 . The goal of this outcome is to allow the developmental trajectory of gender identity to unfold without pursuing or encouraging a specific outcome [50] [51] [52] . It does not exclude active support of the child's social integration and wellbeing, in order to minimize social risks and stressors, and self-recognition of gender variance can be encouraged, and behavioural, cognitive and emotional coping strategies can be promoted 50, 53, 54 . The third approach is based on the concept that abstaining from medical intervention could do even more harm to the child. In this framework, health-care professionals and carers should actively support the child's affirmation as a member of the desired gender. As a consequence, the option of endocrine treatment to suspend and/or suppress puberty should be considered, in order to facilitate a gradual and more efficient gender transition. The rationale for supporting transition before puberty is the belief that some children will still express a stable pattern of gender variance into adulthood. Enabling them to make important age-appropriate developmental transitions, puberty suppression (and subsequent sex reassignment procedures, such as cross-sex hormonal treatment and gender reassignment surgery) would contribute to a satisfactory objective and subjective well-being in young adulthood 41 , and a more favourable surgical outcome 55 . Accordingly, under going the pubertal development of their biological sex could increase the distress already associated with the condition, with serious risks for the individual's psycho logical well-being 56 . As studies have indicated that cross-sex hormonal treatment improves wellbeing in adults with gender dysphoria [57] [58] [59] , research has begun to focus on the effects of puberty suppression on quality of life in prepubertal and adolescent individuals with gender dysphoria, indicating that this early intervention could improve their psychosocial functioning and well being [40] [41] [42] . However, the available evidence is currently too limited to draw definite conclusions. A team from the Netherlands has been an influential leader in promoting a protocol -the so-called Dutch protocol -which recommends treatment of minors with gender dysphoria after an extensive psychological and psychiatric evaluation, with puberty suppression at the age of 12 years and after the first stages of puberty (Tanner stage 2-3) have been reached 55, 60 
. This team have also provided evidence that no young individual eligible for GnRHa has dropped out of treatment or shown regret during puberty suppression 61, 62 . The cornerstone of this approach is the evidence that, although puberty suppression seems to reduce the gender-dysphoria-related distress [40] [41] [42] and seems to be a relatively safe and reversible procedure 46, 60 , not treating gender dysphoria in childhood cannot be considered a neutral option, as delaying treatment until late adolescence or adulthood might lead to the development of psychiatric concerns, social isolation, and impaired functioning 46 . However, the Dutch team does consider the possibility of delaying eligibility for puberty suppression in patients with concomitant psychiatric or psychosocial difficulties requiring intervention.
Balancing observation and intervention. Although medical treatment and health risks 63 in gender-dysphoric adults are well defined and have been the object of more extended research in clinical settings [57] [58] [59] , the treatment strategy for young persons has received little attention in clinical research settings and is still debated 56 . According Figure 1 | Puberty suppression. Suppression of puberty involves the use of GnRHa to halt the progression of puberty by blocking the activity of the GnRH receptor at the pituitary level, which results in decreased release of the gonadotropins LH and FSH. As a consequence, reduced gonadal stimulation leads to a decrease in the release of sex steroids (testosterone from the testes and oestrogen from the ovaries). Without exposure to the sex steroids, the body does not develop secondary sexual characteristics. CNS, central nervous system; FSH, follicle-stimulating hormone; GnRHa, gonadotropin-releasing hormone analogues; LH, luteinizing hormone.
to the Task Force for gender dysphoria, specific healthcare pathways for young individuals with gender dysphoria have not been properly investigated owing to the absence of randomized or adequately controlled longitudinal studies 39 . As a consequence, conclusive treatment recommendations for puberty suppression cannot be made. Clinicians disagree about the appropriateness of puberty suppression because of their professional background and religious or ethical convictions, and the individual, their carers, or the health-care professionals could hold different views, making even more difficult to reach agreed solutions.
In their Task Force treatment recommendation, Byne and colleagues 39 suggest that any treatment decision in children presenting with gender-variant behaviour should be made only after extensive evaluation of the patient's gender-related issues, including identity, role, and behaviour, after addressing any potential concerns of the caregivers or difficulties in their relationship with the patient, and after providing psychoeducation, counselling, and informed consent to any treatment option and outcome from caregivers, in order to support their decision. Treatment should only be initiated after disclosing the limitations of the available data on both outcome and risks of the treatment, having provided information to the child that can be understood, and only in the context of the patient's mental health and psychosocial environment, including family, school, and larger community.
In an attempt to balance the benefits and risks of puberty suppression, and in light of all the available information and knowledge, our opinion is that the enlightened decision would be to allow puberty suppression when the adverse outcomes of a lack of or delayed intervention outweigh the adverse outcomes of early intervention in terms of long-term risks for the child. In other words, if allowing puberty to progress seems likely to harm the child in terms of psychosocial and mental wellbeing, puberty should be suspended.
A multidisciplinary approach Psychological support. The treatment protocol for individuals with gender dysphoria should include a number of different components in order to promote the most satisfactory outcome 64, 65 . The two main goals of gender dysphoria treatment are to support the patient's transition, aligning the phenotype with the experienced and/or expressed gender identity, and to support their psychosocial wellbeing. These outcomes are interlinked and are better achieved using a multidisciplinary approach, involving both physical and nonphysical interventions 41 . Although medical and surgical interventions are fundamental to obtaining a physical appearance in line with the desired gender, psychotherapy and psychological support are considered of great importance in helping the individual to identify and work through the factors that will contribute to his or her decision to undergo cross-sex medical intervention. Psychological and psycho therapeutic settings give patients the opportunity to discuss their behaviour, emotions, and ideas with regard to themselves and possible life problems or events 40 ; gender-dysphoric individuals can experience discomfort with their gender incongruence as a result of internalizing society's normative gender expectations, discrimination, and prejudice 66 . Finally, psychological interventions are also important in the management of posthormonal and surgical outcomes, in order to promote the patient's sense of control and psychological integration of gender role and identity 67 . Thus, psychological support is essential in the assessment, formulation and clinical management of gender dysphoria, owing to the complexity and specific needs of gender-dysphoric individuals at different ages. A variety of psychotherapeutic and psychosocial interventions for gender dysphoria in children are well established, including individual insight-oriented psychoanalytic or psychodynamic psychotherapy, protocol-driven psycho therapy such as behaviour modification, parent and peer relations-focused therapy, and parent and child therapeutic groups, along with educational approaches 39 .
Physical interventions.
Physical interventions for gender dysphoria fall into two main categories or stages: cross-sex hormonal therapy and gender reassignment procedures. Hormonal treatment involves the administration of cross-sex hormones and is intended to induce the sexual characteristics of the desired gender. Hormone therapy is considered a partially reversible intervention 64, 65 and, according to the Dutch protocol, it should be offered when gender-dysphoric adolescents Box 2 | Safety criteria for puberty suppression 1. Puberty suppression cannot be provided until Tanner stage 2 or 3 is reached a. Age ≥12 years, safely above the gender constancy achievement b. Sufficient experience of one's one natal gender 2. Puberty suppression should be offered after extensive evaluation of the condition, as possible associated psychosocial risk factors and family issues could affect the decision to start the treatment a. The condition must exhibit clear early onset; persistence and/or increase upon entering puberty and high gender-dysphoria-relateddistress levels are likely to predict a positive outcome of puberty suppression b. In the presence of psychiatric comorbidities and/or not full understanding of the child's associated difficulties, the possibility of delaying puberty suppression should be considered and the psychological support should become more relevant c. Support from parents or carers is needed and difficulties in the relationship between patients and their parents or carers should be addressed, considering specific forms of psychotherapy 3. The decision to start puberty suppression is taken only after considering patients' and their carers' concerns and expectations after being fully informed on treatment options and expected outcome a. Potential risks and benefits of proceeding or not proceeding with the treatment should be discussed with patients and their parents or carers, in light of the still limited research evidence b. Psychoeducation, counselling, and informed consent should be provided to patients and their parents or carers, in order to achieve a full understanding and realistic expectations about the treatment effects
4. An agreed decision between health-care professionals, patients, and family members should be pursued a. The health-care providers' role is to support and facilitate patients and their parents or carers' decision b. Disagreements between patients and their parents or carers should be fully addressed, in light of the child's limited ability to make decisions and the need for parents or carers to provide informed consent on their behalf are 16 years old 55, 60 . This intervention is considered sufficiently safe and has the ability to enhance the individual's mental as well as physical health 57, 59 . The final stage of gender transitioning is the contemplation of surgical interventions, which are considered irreversible procedures. Protocol differences exist across countries and centres, but surgery is never carried out on patients <18 years of age, in line with the WPATH Standards of Care 3 . Both hormonal and surgical intervention options are discussed with patients in detail, and during the decision-making process some may choose to undergo only hormonal treatment.
The use of gender reassignment in adults was pioneered in the 1920s, but no corresponding procedure for gender-dysphoric children and adolescents was available until the late 1990s. Since then, puberty suppression has become increasingly accepted as an early intervention in young individuals with clear signs of gender dysphoria 64, 65 .
Suppressing puberty. Suppression of puberty involves the use of GnRHa to halt the progression of puberty by blocking the activity of the GnRH receptor at the pituitary level, which results in decreased gonado tropin release. As a consequence, the reduced gonadal stimulation leads to a decrease in the expression of sex steroids, preventing the development of sexual characteristics or causing them to regress to a certain extent, if the individual has already gone through some phases of pubertal development (FIG. 1) . Puberty suppression is considered a fully reversible procedure 64, 65 and has been proven to be sufficiently safe 68 . Suppression of puberty in children with gender dysphoria has the fundamental benefit for children of giving them time to reflect on their gender identity, obtain real-life experience living as the non-natal gender in dress and behaviour, and determine whether or not they desire the full transition 46 . In our opinion, as the development of a body contrary to the experienced gender has been associated with several psychosocial distress parameters, puberty suppression can be considered a preventive treatment. The procedure has consistently been linked to an improved transition into the desired gender role, including in terms of physical appearance, and a more satisfactory outcome, even in the long term [40] [41] [42] . Nevertheless, the importance of continuing to facilitate and support further research on the effects of GnRHa cannot be overemphasized.
Conclusions
In order to better understand the implications of GnRHa for the psychological and physical wellbeing of individuals with childhood-onset gender dysphoria in the long term, further studies are needed to directly compare adolescents who underwent an early intervention protocol including puberty suppression and adolescents who did not. To date, the absence of robust data in support or against the use of GnRHa in the clinical management of childhood-onset gender dysphoria has led to inconsistencies between the approaches recommended by health-care professionals across different centres. The paucity of published research on the effects of GnRHa on health-related outcome measures calls for studies that might help to advance the evidence-based debate on risks and benefits of puberty suppression. However, careful review of the available data does enable the definition of a number of safety criteria for its use
. Despite a limited number of studies, the existing literature supports puberty suppression as an early, sufficiently safe, and preventive treatment for gender dysphoria in childhood and adolescence.
